SCHEMBL31399059

SCHEMBL31399059

CCOC(=O)C(=CNc1ccc(OC)cc1)C(=O)c1cccc(Br)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.52
KDM4E B2RXH2 6/20 0.47
NPSR1 Q6W5P4 5/20 0.47
MAPT P10636 7/20 0.46
ALDH1A1 P00352 5/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 3/20 0.46
HTT P42858 1/20 0.46
CYP19A1 P11511 2/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GAA P10253 1/20 0.44
CYP3A4 P08684 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
RECQL P46063 1/20 0.44
CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31399058 1.00 DHODH (0.52) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL29254489 1.00 DHODH (0.52) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL31399053 0.92 DHODH (0.55) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL29254469 0.88 DHODH (0.55) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL9874767 0.88 DHODH (0.58) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL31399070 0.84 DHODH (0.54) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL29254487 0.84 DHODH (0.54) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL545096 0.82 DHODH (0.75) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL7068076 0.79 DHODH (0.65) DHODHKDM4ENPSR1MAPTALDH1A1
SCHEMBL1429754 0.79 DHODH (0.70) DHODHKDM4ENPSR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF LOMOND THERAPEUTICS, INC. 2025-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250011319-A1 SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOF FLT3, PDXK, PHKG1 DHODH 1081/4885KDM4E 2039/4885NPSR1 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.